{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:16Z","timestamp":1753890616790,"version":"3.41.2"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/12634-9"],"award-info":[{"award-number":["2011\/12634-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2018.00136","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:27:00Z","timestamp":1538144820000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["CD100 Effects in Macrophages and Its Roles in Atherosclerosis"],"prefix":"10.3389","volume":"5","author":[{"given":"Maria C. A.","family":"Luque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana K.","family":"Galuppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaina","family":"Capelli-Peixoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz S.","family":"Stolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1161\/hs1101.098524","article-title":"Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank","volume":"32","author":"Grau","year":"2001","journal-title":"Stroke"},{"key":"B2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nrm2596","article-title":"Mechanotransduction in vascular physiology and atherogenesis","volume":"10","author":"Hahn","year":"2009","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/ATVBAHA.110.221127","article-title":"Monocyte and macrophage dynamics during atherogenesis","volume":"31","author":"Ley","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11883-014-0435-z","article-title":"Inflammation and cardiovascular disease: from pathogenesis to therapeutic target","volume":"16","author":"Golia","year":"2014","journal-title":"Curr Atheroscler Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","article-title":"Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions","volume":"276","author":"Raggi","year":"2018","journal-title":"Atherosclerosis"},{"key":"B8","first-page":"181","article-title":"The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions","volume":"103","author":"Gerrity","year":"1981","journal-title":"Am J Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2018.01.006","article-title":"Inflammation in human carotid atheroma plaques","volume":"39","author":"Goikuria","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00281\u2013009-0141-z","article-title":"Myeloid cells in atherosclerosis: initiators and decision shapers","volume":"31","author":"Soehnlein","year":"2009","journal-title":"Semin Immunopathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2018.08.004","article-title":"The salient role of microRNAs in atherogenesis","volume":"122","author":"Donaldson","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/gb-2006-7-3-211","article-title":"The semaphorins","volume":"7","author":"Yazdani","year":"2006","journal-title":"Genome Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrrheum.2017.201","article-title":"The role of semaphorins in immune responses and autoimmune rheumatic diseases","volume":"14","author":"Nishide","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/cmi.2009.111","article-title":"Regulation of immune cell responses by semaphorins and their receptors","volume":"7","author":"Takamatsu","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/cr.2011.198","article-title":"Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer","volume":"22","author":"Sakurai","year":"2012","journal-title":"Cell Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1080\/19336918.2016.1197478","article-title":"The role of the semaphorins in cancer","volume":"10","author":"Neufeld","year":"2016","journal-title":"Cell Adh Migr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tibs.2008.01.006","article-title":"Semaphorin signaling: progress made and promises ahead","volume":"33","author":"Zhou","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.molmed.2014.07.005","article-title":"Semaphorins in cardiovascular medicine","volume":"20","author":"Cora","year":"2014","journal-title":"Trends Mol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.112.301155","article-title":"Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions","volume":"33","author":"van Gils","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/ATVBAHA.112.300941","article-title":"Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention","volume":"33","author":"Wanschel","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/cvr\/cvx190","article-title":"Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation","volume":"113","author":"Wu","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/ATVBAHA.117.310491","article-title":"Vascular Semaphorin 7A upregulation by disturbed flow promotes atherosclerosis through endothelial beta1 integrin","volume":"38","author":"Hu","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clim.2015.12.012","article-title":"Soluble SEMA4D\/CD100: A novel immunoregulator in infectious and inflammatory diseases","volume":"163","author":"Maleki","year":"2016","journal-title":"Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00011-016-0983-5","article-title":"Semaphorins 4A and 4D in chronic inflammatory diseases","volume":"66","author":"Chapoval","year":"2017","journal-title":"Inflammation Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/art.39086","article-title":"Semaphorin 4D contributes to rheumatoid arthritis by inducing inflammatory cytokine production: pathogenic and therapeutic implications","volume":"67","author":"Yoshida","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4049\/jimmunol.0903302","article-title":"Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis","volume":"184","author":"Okuno","year":"2010","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41408-018-0075-6","article-title":"Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma","volume":"8","author":"Terpos","year":"2018","journal-title":"Blood Cancer J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/annrheumdis-2016-210706","article-title":"Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis","volume":"76","author":"Nishide","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1182\/blood.V97.11.3498","article-title":"Functional soluble CD100\/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses","volume":"97","author":"Wang","year":"2001","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.molimm.2015.07.028","article-title":"CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis","volume":"67","author":"Luque","year":"2015","journal-title":"Mol Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.4049\/jimmunol.166.7.4341","article-title":"Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis","volume":"166","author":"Elhabazi","year":"2001","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8057","DOI":"10.4049\/jimmunol.180.12.8057","article-title":"IFN-gamma and STAT1 arrest monocyte migration and modulate RAC\/CDC42 pathways","volume":"180","author":"Hu","year":"2008","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1365-2567.2009.03098.x","article-title":"Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis","volume":"128","author":"Li","year":"2009","journal-title":"Immunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1073\/pnas.0606344104","article-title":"Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4049\/jimmunol.148.2.318","article-title":"Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation","volume":"148","author":"Bougeret","year":"1992","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e75772","DOI":"10.1371\/journal.pone.0075772","article-title":"Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells","volume":"8","author":"Luque","year":"2013","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1074\/jbc.M609570200","article-title":"MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D","volume":"282","author":"Basile","year":"2007","journal-title":"J Biol Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1615\/CritRevImmunol.v23.i12.40","article-title":"Structure and function of the immune semaphorin CD100\/SEMA4D","volume":"23","author":"Elhabazi","year":"2003","journal-title":"Crit Rev Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri1003","article-title":"Semaphorins in interactions between T cells and antigen-presenting cells","volume":"3","author":"Kikutani","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1074\/jbc.RA118.002175","article-title":"Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D","volume":"293","author":"Motani","year":"2018","journal-title":"J Biol Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-008-9263-7","article-title":"Immune semaphorins: novel features of neural guidance molecules","volume":"29","author":"Mizui","year":"2009","journal-title":"J Clin Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1084\/jem.20072602","article-title":"Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages","volume":"205","author":"Sierra","year":"2008","journal-title":"J Exp Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1074-7613(00)00062-5","article-title":"Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling","volume":"13","author":"Kumanogoh","year":"2000","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1074-7613(00)00063-7","article-title":"The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice","volume":"13","author":"Shi","year":"2000","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/intimm\/dxh224","article-title":"Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively","volume":"17","author":"Chabbert-de Ponnat","year":"2005","journal-title":"Int Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.4049\/jimmunol.166.7.4348","article-title":"Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration","volume":"166","author":"Delaire","year":"2001","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3389\/fmicb.2018.01177","article-title":"CD100\/Sema4D increases macrophage infection by Leishmania (Leishmania) amazonensis in a CD72 dependent manner","volume":"9","author":"Galuppo","year":"2018","journal-title":"Front Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0092-8674(00)80063-X","article-title":"Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates","volume":"99","author":"Tamagnone","year":"1999","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1158\/0008-5472.CAN-04-0126","article-title":"Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B","volume":"64","author":"Basile","year":"2004","journal-title":"Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/intimm\/dxg098","article-title":"Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses","volume":"15","author":"Ishida","year":"2003","journal-title":"Int Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1182\/blood-2002-05-1339","article-title":"CD100\/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes","volume":"101","author":"Granziero","year":"2003","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.icb.7100123","article-title":"Axon growth and guidance genes identify T-dependent germinal centre B cells","volume":"86","author":"Yu","year":"2008","journal-title":"Immunol Cell Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.immuni.2012.05.026","article-title":"The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal gammadelta T cell function","volume":"37","author":"Witherden","year":"2012","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e24795","DOI":"10.1371\/journal.pone.0024795","article-title":"Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation","volume":"6","author":"Roney","year":"2011","journal-title":"PLoS ONE"},{"key":"B57","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1017\/S003118201600024X","article-title":"Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB\/c, BALB\/c nude and C57BL\/6 mice","volume":"143","author":"Velasquez","year":"2016","journal-title":"Parasitology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2172-12-30","article-title":"Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor","volume":"12","author":"Smith","year":"2011","journal-title":"BMC Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.4049\/jimmunol.0902450","article-title":"CD72 negatively regulates KIT-mediated responses in human mast cells","volume":"184","author":"Kataoka","year":"2010","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1471-4906(01)02087-7","article-title":"The CD100-CD72 interaction: a novel mechanism of immune regulation","volume":"22","author":"Kumanogoh","year":"2001","journal-title":"Trends Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12026-010-8201-y","article-title":"Biology and function of neuroimmune semaphorins 4A and 4D","volume":"50","author":"Nkyimbeng-Takwi","year":"2011","journal-title":"Immunol Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/ATVBAHA.109.185405","article-title":"Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis","volume":"29","author":"Zhu","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3892\/ijmm_00000432","article-title":"Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice","volume":"26","author":"Yukawa","year":"2010","journal-title":"Int J Mol Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.colsurfb.2018.07.062","article-title":"Real-time QCM-D monitoring of endothelial cells and macrophages adhering and spreading to SEMA4D\/heparin surfaces. Colloids and surfaces B","volume":"171","author":"Cui","year":"2018","journal-title":"Biointerfaces"},{"key":"B65","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ehf2.12275","article-title":"Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?","volume":"5","author":"Willner","year":"2018","journal-title":"ESC Heart Failure"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e64265","DOI":"10.1371\/journal.pone.0064265","article-title":"Increased levels of plasma soluble Sema4D in patients with heart failure","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS ONE"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.12659\/MSM.895441","article-title":"Serum soluble semaphorin 4D is associated with left atrial diameter in patients with atrial fibrillation","volume":"21","author":"Xiang","year":"2015","journal-title":"Med. Sci. Monitor"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.7314\/APJCP.2013.14.10.5883","article-title":"Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer","volume":"14","author":"Chen","year":"2013","journal-title":"Asian Pac J Cancer Prevent"},{"key":"B69","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fimmu.2014.00579","article-title":"Dynamic aspects of macrophage polarization during atherosclerosis progression and regression","volume":"5","author":"Peled","year":"2014","journal-title":"Front Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/2326-6066.CIR-14-0171","article-title":"Antibody blockade of semaphorin 4D promotes immune infiltration into tumor and enhances response to other immunomodulatory therapies","volume":"3","author":"Evans","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/19420862.2015.1102813","article-title":"Generation and preclinical characterization of an antibody specific for SEMA4D","volume":"8","author":"Fisher","year":"2016","journal-title":"mAbs"},{"key":"B72","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/1078-0432.CCR-15-0431","article-title":"Safety, pharmacokinetics, and pharmacodynamics of a humanized anti-semaphorin 4D antibody, in a first-in-human study of patients with advanced solid tumors","volume":"22","author":"Patnaik","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1212\/NXI.0000000000000367","article-title":"Safety\/tolerability of the anti-semaphorin 4D antibody VX15\/2503 in a randomized phase 1 trial","volume":"4","author":"LaGanke","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T13:22:15Z","timestamp":1693920135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":73,"alternative-id":["10.3389\/fcvm.2018.00136"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2018.00136","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"article-number":"136"}}